Abstract
Cardiac involvement is an important cause of mortality in patients with Churg-Strauss syndrome. The typical cardiac presentation of Churg-Strauss syndrome includes pericarditis, myocarditis, and cardiomyopathy. Endomyocardial fibrosis has rarely been described in patients with Churg-Strauss syndrome. We experienced a patient with Churg-Strauss syndrome who exhibited exertional dyspnea and endomyocardial fibrosis visualized as delayed enhancement on cardiac magnetic resonance imaging (MRI). After glucocorticoid treatment, the patient's symptom resolved, and the eosinophil count decreased to normal. Nine months later, the delayed-enhanced lesion on the cardiac MRI nearly disappeared. Here, we report a case of endomyocardial fibrosis in a patient with Churg-Strauss syndrome with a literature review.
REFERENCES
1). Churg J., Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951. 27:277–311.
2). Pagnoux C., Guilpain P., Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol. 2007. 19:25–32.
3). Lanham J., Cooke S., Davies J., Hughes G. Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J. 1985. 61:341–4.
4). Oh M., Lee J., Kwon N., Choi D. Churg-Strauss syndrome: the clinical features and long-term follow-up of 17 patients. J Korean Med Sci. 2006. 21:265–71.
5). Masi AT., Hunder GG., Lie JT., Michel BA., Bloch DA., Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990. 33:1094–100.
6). Sinico RA., Di Toma L., Maggiore U., Bottero P., Radice A., Tosoni C, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005. 52:2926–35.
7). Sable-Fourtassou R., Cohen P., Mahr A., Pagnoux C., Mouthon L., Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005. 143:632–8.
8). Wassmuth R., Gobel U., Natusch A., Schneider W., Kettritz R., Dietz R, et al. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail. 2008. 14:856–60.
9). Alter P., Maisch B. Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol. 2006. 108:112–3.
10). Moon J., Reed E., Sheppard M., Elkington A., Ho S., Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004. 43:2260–4.
11). Laissy JP., Messin B., Varenne O., Iung B., Karila-Cohen D., Schouman-Claeys E, et al. MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest. 2002. 122:1638–48.
12). Pfeil A., Brehm B., Lopatta E., Neumann T., Schmidt P., Wolf G, et al. Acute chest pain, heart failure, and eosinophilia in a woman without coronary disease. Cardiovasc Intervent Radiol. 2009. 32:1272–4.
13). Baccouche H., Yilmaz A., Alscher D., Klingel K., Val-Bernal J., Mahrholdt H. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome. Circulation. 2008. 117:1745–9.
14). Ribi C., Cohen P., Pagnoux C., Mahr A., Arene J., Lauque D, et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008. 58:586–94.
15). Guillenvin L., Lhote F., Gayraud M., Cohen P., Jarrouse B., Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore). 1996. 75:17–28.